TY  - RPRT
TI  - A Seamless Phase II/III Design with Dose Optimization for Oncology Drug Development
AU  - Yuhan Li
AU  - Yiding Zhang
AU  - Gu Mi
AU  - Ji Lin
PY  - 2024
UR  - https://arxiv.org/abs/2406.00196
ID  - 2406.00196
ER  -